Antiphospholipid antibody induction after infliximab treatment for inflammatory bowel disease

被引：0
|
作者：
Wheeler, Jason [1 ]
机构：
[1] Cleveland Clin, Cleveland, OH 44106 USA
来源：
VASCULAR MEDICINE | 2021年 / 26卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
1411
引用
收藏
页码：NP32 / NP33
页数：2
相关论文
共 50 条
  • [1] Outcomes After Primary Infliximab Treatment Failure in Inflammatory Bowel Disease
    Buhl, Sine
    Steenholdt, Casper
    Rasmussen, Maria
    Borghede, Marta K.
    Brynskov, Jorn
    Thomsen, Ole O.
    Ainsworth, Mark A.
    INFLAMMATORY BOWEL DISEASES, 2017, 23 (07) : 1210 - 1217
  • [2] Infliximab trough levels after induction therapy are predictive for infliximab efficacy in paediatric patients with inflammatory bowel disease
    van Hoeve, K.
    Hoffman, I.
    Dreesen, E.
    Ferrante, M.
    Gils, A.
    Vermeire, S.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S183 - S183
  • [3] Personalized infliximab treatment of adolescents with inflammatory bowel disease
    Carlsen, K.
    Jakobsen, C.
    Hansen, L.
    Paerregaard, A.
    Munkholm, P.
    Wewer, V.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S408 - S408
  • [4] Minimizing infliximab toxicity in the treatment of inflammatory bowel disease
    Orlando, A.
    Mocciaro, F.
    Civitavecchia, G.
    Scimeca, D.
    Cottone, M.
    DIGESTIVE AND LIVER DISEASE, 2008, 40 : S236 - S246
  • [5] Infliximab in inflammatory bowel disease
    Papamichael, Konstantinos
    Lin, Steve
    Moore, Matthew
    Papaioannou, Garyfallia
    Sattler, Lindsey
    Cheifetz, Adam S.
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2019, 10
  • [6] Trough serum infliximab level, anti-infliximab antibody status and response to infliximab maintenance treatment in inflammatory bowel disease (IBD)
    Kong, J. Y.
    Bundell, C. S.
    Pawlik, J.
    Hollingsworth, P. N.
    Forbes, G. M.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 59 - 60
  • [7] A role for therapeutic drug-monitoring during infliximab induction treatment in inflammatory bowel disease?
    Rasmussen, M.
    Brynskov, J.
    Ainsworth, M. A.
    Buhl, S.
    Bendtzen, K.
    Steenholdt, C.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S378 - S378
  • [8] Safety of infliximab treatment in pediatric patients with inflammatory bowel disease
    Scarbrough, M
    Calabro, C
    Carpenter, E
    Bendorf, K
    Friesen, CA
    Roberts, CC
    Daniel, JF
    Hodge, C
    GASTROENTEROLOGY, 2003, 124 (04) : A519 - A519
  • [9] Clinical Pharmacokinetics and Pharmacodynamics of Infliximab in the Treatment of Inflammatory Bowel Disease
    Hemperly, Amy
    Vande Casteele, Niels
    CLINICAL PHARMACOKINETICS, 2018, 57 (08) : 929 - 942
  • [10] Adherence to Infliximab Treatment in a Pediatric Inflammatory Bowel Disease Cohort
    Vitale, David S.
    Greenley, Rachel N.
    Lerner, Diana G.
    Mavis, Alisha M.
    Werlin, Steven L.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2015, 61 (04): : 408 - 410
12345